Skip to main content
Erschienen in: Herz 6/2017

10.11.2016 | Original articles

Association between microRNA polymorphisms and coronary heart disease

A meta-analysis

verfasst von: X. Xie, MD, X. Shi, MD, X. Xun, BS, L. Rao, MD, PhD

Erschienen in: Herz | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The association between microRNA polymorphisms (miR polymorphisms) and coronary heart disease (CHD) risk has been studied intensively, but the results have been conflicting. Therefore, we conducted the present meta-analysis to obtain a more conclusive answer. We searched for eligible articles in PubMed, MEDLINE, EMBASE, Scopus, and CNKI. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to identify any potential associations. Ten case-control studies including 5,292 CHD patients and 5,446 control subjects were analyzed. The overall meta-analysis results showed that the miR-146a rs2910164 polymorphism, the miR-196a2 rs11614913 polymorphism, and the miR-499 rs3746444 polymorphism were all significantly associated with CHD risk in certain genetic models. Besides, the C allele of the miR-146a rs2910164 and miR-499 rs3746444 polymorphisms conferred increased susceptibility to CHD (C versus G, p < 0.0001, OR = 1.14, 95% CI = 1.07–1.21; p = 0.003, OR = 1.14, 95% CI = 1.05–1.25). Overall, our findings suggest that the miR-146a rs2910164, miR-196a2 rs11614913, and miR-499 rs3746444 polymorphisms may be correlated with the risk of CHD.

Literatur
  1. Moran AE, Forouzanfar MH, Roth G et al (2014) The global burden of Ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation 129:1493–1501View ArticlePubMedPubMed Central
  2. Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800View ArticlePubMed Central
  3. Mayer B, Erdmann J, Schunkert H (2007) Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol 96:1–7View ArticlePubMed
  4. Evans A, Van Baal GC, McCarron P et al (2003) The genetics of coronary heart disease: the contribution of twin studies. Twin Res 6:432–441View ArticlePubMed
  5. Kangas-Kontio T, Huotari A, Ruotsalainen H et al (2010) Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease. Atherosclerosis 210:479–485View ArticlePubMed
  6. Sayols-Baixeras S, Lluís-Ganella C, Lucas G, Elosua R (2014) Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet 7:15–32PubMedPubMed Central
  7. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149:515–524View ArticlePubMedPubMed Central
  8. lshatwi AA, Shafi G, Hasan TN et al (2012) Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLOS ONE 7:e30049View Article
  9. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10:389–402View ArticlePubMedPubMed Central
  10. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605View ArticlePubMed
  11. Bastami M, Ghaderian SM, Omrani MD et al (2016) MiRNA-related polymorphisms in miR-146a and TCF21 are associated with increased susceptibility to coronary artery disease in an Iranian population. Genet Test Mol Biomarkers 20:241–248View ArticlePubMed
  12. Chen L, Wu YT (2013) Association of genetic polymorphisms in microRNAs precursor with the risk and prognosis of coronary heart disease. Acad J Xian Jiaotong Univ 34:495–499
  13. Chen C, Hong H, Chen L et al (2014) Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J Exp Med 233:89–94View ArticlePubMed
  14. Hamann L, Glaeser C, Schulz S et al (2014) A micro RNA-146a polymorphism is associated with coronary restenosis. Int J Immunogenet 41:393–396View ArticlePubMed
  15. Huang S, Lv Z, Deng Q et al (2015) A genetic variant in pre-miR-146a (rs2910164 C>G) is associated with the decreased risk of acute coronary syndrome in a Chinese population. Tohoku J Exp Med 237:227–233View ArticlePubMed
  16. Li L (2010) Association of miRNA-146a polymorphism with risk of cardiovascular disease and ischemia stroke and the mechanisms. Dissertation. Central South University, Hunan
  17. Ramkaran P, Khan S, Phulukdaree A et al (2014) miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 68:259–266View ArticlePubMed
  18. Xiong XD, Cho M, Cai XP et al (2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res 761:15–20View ArticlePubMed
  19. Yang Y (2012) Common genetic variations in pre-miRNAs and the risk of coronary heart disease in a Chinese Han population. Dissertation. Peking Union Medical College, Beijing
  20. Zhi H, Wang L, Ma G et al (2012) Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol 101:289–296View ArticlePubMed
  21. Lloyd-Jones DM, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease. Lancet 353:89–92View ArticlePubMed
  22. Braunwald E (1997) Shattuck lecture – cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369View ArticlePubMed
  23. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355View ArticlePubMed
  24. Hogg DR, Harries LW (2014) Human genetic variation and its effect on miRNA biogenesis, activity and function. Biochem Soc Trans 42:1184–1189View ArticlePubMed
  25. Huang S, Zhou S, Zhang Y et al (2015) Association of the genetic polymorphisms in pre-MicroRNAs with risk of ischemic stroke in a Chinese population. PLOS ONE 10:e0117007View ArticlePubMedPubMed Central
  26. Shen J, Ambrosone CB, DiCioccio RA et al (2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29:1963–1966View ArticlePubMed
  27. Hoffman AE, Zheng T, Yi C et al (2009) MicroRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 69:5970–5977View ArticlePubMedPubMed Central
  28. El Gazzar GM, Church A, Liu T, McCall CE (2011) MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-a during TLR4-induced gene reprogramming. J Leukoc Biol 90:509–519View ArticlePubMedPubMed Central
  29. Luthra R, Singh RR, Luthra MG et al (2008) MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27:6667–6678View ArticlePubMed
  30. Yang B, Chen J, Li Y et al (2012) Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. Hum Immunol 73:101–106View ArticlePubMed
Metadaten
Titel
Association between microRNA polymorphisms and coronary heart disease
A meta-analysis
verfasst von
X. Xie, MD
X. Shi, MD
X. Xun, BS
L. Rao, MD, PhD
Publikationsdatum
10.11.2016
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2017
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-016-4495-4

Weitere Artikel der Ausgabe 6/2017

Herz 6/2017 Zur Ausgabe

Editorial

Aortenklappe

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.